The Uncertain Effect of Antimicrobial Therapy in the Treatment of Patients with Ischemic Colitis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Jae Gon | - |
dc.contributor.author | Park, Jin Hwa | - |
dc.contributor.author | Han, Dong Soo | - |
dc.contributor.author | Lee, Hang Lak | - |
dc.contributor.author | Park, Chan Hyuk | - |
dc.contributor.author | Eun, Chang Soo | - |
dc.date.accessioned | 2021-08-02T09:26:15Z | - |
dc.date.available | 2021-08-02T09:26:15Z | - |
dc.date.created | 2021-05-11 | - |
dc.date.issued | 2020-07 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/9697 | - |
dc.description.abstract | Although antimicrobial therapy is recommended for patients with moderate or severe ischemic colitis, its beneficial effects are unclear. In the present study, the role of antimicrobial therapy in the treatment of ischemic colitis was investigated. Patients with ischemic colitis were retrospectively identified between January 2004 and June 2019. The characteristics and outcomes of patients who received antibiotics (antibiotics group) and those who did not (no-antibiotics group) were compared. Clinical outcomes included death, surgery, and readmission within 30 days, fasting duration, and hospital stay. Data from 186 patients were analyzed; 122 patients were in the antibiotics group and 64 in the no-antibiotics group. Composite outcome of death, surgery, and readmission within 30 days occurred in 3.3% of patients in the antibiotics group and 3.1% of patients in the no-antibiotics group (p> 0.999). Fasting duration was not significantly different between the two groups (median days, 4.0 vs. 4.0,p= 0.253). However, hospital stays were longer in the antibiotics group than in the no-antibiotics group (median days, 9.0 vs. 7.0,p= 0.043). In patients with ischemic colitis, there was no statistically significant difference in the incidence of death, surgery, and readmission within 30 days between patients who received antibiotics and those who did not receive antibiotics. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.title | The Uncertain Effect of Antimicrobial Therapy in the Treatment of Patients with Ischemic Colitis | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Han, Dong Soo | - |
dc.contributor.affiliatedAuthor | Park, Chan Hyuk | - |
dc.contributor.affiliatedAuthor | Eun, Chang Soo | - |
dc.identifier.doi | 10.3390/jcm9072182 | - |
dc.identifier.scopusid | 2-s2.0-85114278775 | - |
dc.identifier.wosid | 000554194500001 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL MEDICINE, v.9, no.7, pp.1 - 11 | - |
dc.relation.isPartOf | JOURNAL OF CLINICAL MEDICINE | - |
dc.citation.title | JOURNAL OF CLINICAL MEDICINE | - |
dc.citation.volume | 9 | - |
dc.citation.number | 7 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 11 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | RISK-FACTORS | - |
dc.subject.keywordPlus | INTESTINAL ISCHEMIA | - |
dc.subject.keywordPlus | OUTCOMES | - |
dc.subject.keywordPlus | PATTERNS | - |
dc.subject.keywordAuthor | ischemic colitis | - |
dc.subject.keywordAuthor | anti-bacterial agents | - |
dc.subject.keywordAuthor | treatment outcome | - |
dc.subject.keywordAuthor | prognosis | - |
dc.identifier.url | https://www.mdpi.com/2077-0383/9/7/2182 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.